Full Text View
Tabular View
No Study Results Posted
Related Studies
Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP
This study has been completed.
Study NCT00204308   Information provided by University of Alabama at Birmingham
First Received: September 12, 2005   Last Updated: February 5, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV
Pregnancy
Additional drug interventions recognized in this trial
Emtricitabine
Reverse Transcriptase Inhibitors
Tenofovir
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Alabama at Birmingham


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services